E
Medicenna Therapeutics Corp. MDNA.TO
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025
Revenue -- --
Total Other Revenue -- --
Total Revenue -- --
Cost of Revenue -- --
Gross Profit -- --
SG&A Expenses 10.24% -28.79%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses -0.08% 8.95%
Operating Income 0.08% -8.95%
Income Before Tax -530.64% 122.30%
Income Tax Expenses -- --
Earnings from Continuing Operations -530.64% 122.30%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income -530.64% 122.30%
EBIT 0.08% -8.95%
EBITDA 0.32% -8.90%
EPS Basic -507.55% 122.32%
Normalized Basic EPS -509.09% 122.22%
EPS Diluted -507.55% 122.32%
Normalized Diluted EPS -509.09% 122.22%
Average Basic Shares Outstanding 5.55% 0.23%
Average Diluted Shares Outstanding 5.55% 0.23%
Dividend Per Share -- --
Payout Ratio -- --